Show simple item record

dc.contributor.authorAllen, Claire
dc.date.accessioned2020-03-24T12:44:52Z
dc.date.available2020-03-24T12:44:52Z
dc.date.issued2020-03-22
dc.identifier.urihttps://www.evidenceaid.org/buffered-solutions-did-not-reduce-mortality-compared-to-0-9-saline-for-resuscitation-in-critically-ill-adults-and-children/en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/768
dc.description.abstractWhat is this? Some patients with COVID-19 will become critically ill and need intravenous fluids. Saline 0.9% is the most commonly used crystalloid solutions for critically ill patients, but buffered solutions are also used. In this Cochrane systematic review, the authors searched for randomized trials evaluating buffered solutions versus intravenous 0.9% saline for adults and children in critical care. They did not restrict by type, date or language of publication and did their searches in July 2018. They identified 21 eligible studies (20,213 participants, with 94% of these patients in three of the trials), and three ongoing studies.en_US
dc.languageEnglishen_US
dc.subjectMortalityen_US
dc.subjectChild Healthen_US
dc.subjectAdults Healthen_US
dc.subjectInfectious Diseasesen_US
dc.subjectCritical Illness
dc.titleBuffered solutions did not reduce mortality compared to 0.9% saline for resuscitation in critically ill adults and childrenen_US
eihealth.countryOthersen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySlow Spread / Reducir la Dispersiónen_US
dc.relation.ispartofjournalEvidence Aiden_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record